Rania Nafi' Suleiman Alsabi, Amilia Afzan Mohd Jamil, Rima Anggrena Dasrilsyah, Aishah Siddiqah Alimuddin, Ruthpackiavathy Rajen Durai
{"title":"Do We Actually Need a New Scale? Improving Postpartum Depression Screening in Malaysia: A Narrative Literature Review.","authors":"Rania Nafi' Suleiman Alsabi, Amilia Afzan Mohd Jamil, Rima Anggrena Dasrilsyah, Aishah Siddiqah Alimuddin, Ruthpackiavathy Rajen Durai","doi":"10.21315/mjms-05-2025-341","DOIUrl":null,"url":null,"abstract":"<p><p>Postpartum depression (PPD) is a major maternal health concern in Malaysia, impacting both maternal well-being and infant development. Despite the availability of several validated screening tools, concerns remain about their cultural appropriateness and diagnostic accuracy in Malaysia's multiethnic context. This narrative review critically evaluates the psychometric properties, contextual relevance, and clinical limitations of PPD screening tools used in Malaysian healthcare. The objective is to assess whether current instruments sufficiently detect PPD in Malaysian women and explore the rationale for a culturally tailored alternative. A targeted literature search was conducted across six databases-PubMed, Scopus, Ovid MEDLINE, Wiley Online Library, Cochrane, and Google Scholar-for studies published between 2000 and 2024, using keywords such as \"postpartum depression\", \"screening tools\", \"Malaysia\", and \"psychometric validation\". The inclusion criteria focused on studies examining Malaysian populations and reporting on the implementation, psychometric properties, or contextual adaptation of common screening tools. The Edinburgh Postnatal Depression Scale (EPDS), Postpartum Depression Screening Scale (PDSS), and Patient Health Questionnaire-9 (PHQ-9) were the most commonly used tools. Although they demonstrated moderate validity and reliability, their use in Malaysia is limited by suboptimal linguistic translation, poor contextual adaptation, and inconsistent validation procedures. Furthermore, these tools often overlook key sociocultural determinants like postpartum confinement practices, stigma, and healthcare access disparities. This review highlights the inadequacy of foreign-developed PPD screening tools for Malaysian mothers. Thus, a culturally sensitive, empirically validated tool that incorporates biopsychosocial risk factors specific to Malaysia is warranted to enable timely detection, appropriate intervention, and improved maternal mental health outcomes.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"32 4","pages":"74-88"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13132136/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21315/mjms-05-2025-341","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Postpartum depression (PPD) is a major maternal health concern in Malaysia, impacting both maternal well-being and infant development. Despite the availability of several validated screening tools, concerns remain about their cultural appropriateness and diagnostic accuracy in Malaysia's multiethnic context. This narrative review critically evaluates the psychometric properties, contextual relevance, and clinical limitations of PPD screening tools used in Malaysian healthcare. The objective is to assess whether current instruments sufficiently detect PPD in Malaysian women and explore the rationale for a culturally tailored alternative. A targeted literature search was conducted across six databases-PubMed, Scopus, Ovid MEDLINE, Wiley Online Library, Cochrane, and Google Scholar-for studies published between 2000 and 2024, using keywords such as "postpartum depression", "screening tools", "Malaysia", and "psychometric validation". The inclusion criteria focused on studies examining Malaysian populations and reporting on the implementation, psychometric properties, or contextual adaptation of common screening tools. The Edinburgh Postnatal Depression Scale (EPDS), Postpartum Depression Screening Scale (PDSS), and Patient Health Questionnaire-9 (PHQ-9) were the most commonly used tools. Although they demonstrated moderate validity and reliability, their use in Malaysia is limited by suboptimal linguistic translation, poor contextual adaptation, and inconsistent validation procedures. Furthermore, these tools often overlook key sociocultural determinants like postpartum confinement practices, stigma, and healthcare access disparities. This review highlights the inadequacy of foreign-developed PPD screening tools for Malaysian mothers. Thus, a culturally sensitive, empirically validated tool that incorporates biopsychosocial risk factors specific to Malaysia is warranted to enable timely detection, appropriate intervention, and improved maternal mental health outcomes.
期刊介绍:
The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access, fully online journal that is published at least six times a year. The journal’s scope encompasses all aspects of medical sciences including biomedical, allied health, clinical and social sciences. We accept high quality papers from basic to translational research especially from low & middle income countries, as classified by the United Nations & World Bank (https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519), with the aim that published research will benefit back the bottom billion population from these countries. Manuscripts submitted from developed or high income countries to MJMS must contain data and information that will benefit the socio-health and bio-medical sciences of these low and middle income countries. The MJMS editorial board consists of internationally regarded clinicians and scientists from low and middle income countries.